CAS 156053-89-3
:Alvimopan
Description:
Alvimopan is a selective antagonist of the mu-opioid receptor, primarily used in the medical field to manage postoperative ileus, a condition characterized by a temporary cessation of bowel activity following surgery. It works by blocking the effects of opioids on the gastrointestinal tract, thereby promoting bowel motility without affecting analgesia provided by opioids in the central nervous system. Alvimopan is administered orally and is notable for its limited systemic absorption, which minimizes central side effects. The substance has a molecular formula that reflects its complex structure, and it is classified as a small molecule drug. Its pharmacokinetics indicate a rapid absorption and a relatively short half-life, necessitating multiple doses for sustained effect. Alvimopan is typically prescribed in a hospital setting, and its use is generally restricted to specific patient populations due to potential cardiovascular risks associated with long-term use. Overall, Alvimopan represents a targeted approach to managing gastrointestinal side effects in patients receiving opioid therapy.
Formula:C25H32N2O4
InChI:InChI=1/C25H32N2O4/c1-18-16-27(12-11-25(18,2)21-9-6-10-22(28)14-21)17-20(24(31)26-15-23(29)30)13-19-7-4-3-5-8-19/h3-10,14,18,20,28H,11-13,15-17H2,1-2H3,(H,26,31)(H,29,30)/t18-,20-,25+/m0/s1
InChI key:InChIKey=UPNUIXSCZBYVBB-JVFUWBCBSA-N
SMILES:C[C@@]1([C@@H](C)CN(C[C@H](CC2=CC=CC=C2)C(NCC(O)=O)=O)CC1)C3=CC(O)=CC=C3
Synonyms:- 2-([(2S)-2-([(3R,4R)-4-(3-Hydroxyphenyl)-3,4-dimethylpiperidin-1-yl]methyl)-3-phenylpropanoyl]amino)acetic acid
- Adl 8-2698
- Entereg
- Glycine, N-[(2S)-2-[[(3R,4R)-4-(3-hydroxyphenyl)-3,4-dimethyl-1-piperidinyl]methyl]-1-oxo-3-phenylpropyl]-
- Glycine, N-[2-[[4-(3-hydroxyphenyl)-3,4-dimethyl-1-piperidinyl]methyl]-1-oxo-3-phenylpropyl]-, [3R-[1(S*),3α,4α]]-
- Ly 246736
- N-[(2S)-2-[[(3R,4R)-4-(3-Hydroxyphenyl)-3,4-dimethyl-1-piperidinyl]methyl]-1-oxo-3-phenylpropyl]glycine
- N-{(2S)-2-benzyl-3-[(3R,4R)-4-(3-hydroxyphenyl)-3,4-dimethylpiperidin-1-yl]propanoyl}glycine
- 2-((S)-2-benzyl-3-((3R,4R)-4-(3-hydroxyphenyl)-3,4-diMethylpiperidin-1-yl)propanaMido)acetic acid
- Unii-Q153V49p3z
- Alvimopan
- Ly246736
- trans-3,4-Dimethyl-4-(3-hydroxyphenyl) piperidine
- 170098-38-1 (Dihydrate)
- AlviMopan (ADL 8-2698)
- 2-((S)-2-Benzyl-3-((3R,4R)-4-(3-hydroxyphenyl)-3,4-dimethylpiperidin-1-yl)propanamido)acetic a
- See more synonyms
Sort by
Purity (%)
0
100
|
0
|
50
|
90
|
95
|
100
Found 8 products.
Glycine, N-[(2S)-2-[[(3R,4R)-4-(3-hydroxyphenyl)-3,4-dimethyl-1-piperidinyl]methyl]-1-oxo-3-phenylpropyl]-
CAS:Formula:C25H32N2O4Purity:98%Color and Shape:SolidMolecular weight:424.5326Alvimopan
CAS:<p>Alvimopan is a potent opioid antagonist targeting gut receptors to reverse opioid effects on motility.</p>Formula:C25H32N2O4Purity:99.47% - 99.78%Color and Shape:SolidMolecular weight:424.53Alvimopan - Bio-X ™
CAS:<p>Alvimopan is an mu opioid antagonist that is used in the healing of the upper and lower gastrointestinal tract after surgery. This drug is used to avoid postoperative ileus. Alvimopan binds to peripheral mu-type receptors.</p>Formula:C25H32N2O4Purity:Min. 95%Color and Shape:PowderMolecular weight:424.53 g/molAlvimopan
CAS:Controlled Product<p>Applications A peripheral µ-opioid receptor antagonist. Gastroprokinetic.<br>References Zimmerman, D.M., et al.: J. Med. Chem., 37, 2262 (1994), Liu, S.S., et al.: Clin. Pharmacol. Ther., 68, 66 (2000), Taguchi, A., et al.: N. Engl. J. Med., 345, 935 (2001),<br></p>Formula:C25H32N2O4Color and Shape:NeatMolecular weight:424.53Alvimopan
CAS:<p>Peripheral ?-opioid receptor antagonist; gastroprokinetic</p>Formula:C25H32N2O4Purity:Min. 95%Color and Shape:PowderMolecular weight:424.53 g/mol






